On the other hand, incorrect dosage can lead to inadequate blood sugar control or an increased risk of side effects
Newsletter Signup - Under Article / In Page "*" indicates required fields Glucagon-like peptide-1 (GLP-1) receptor agonists, originally approved as treatment in type-2 diabetes, recently became a tremendous success in the obesity market
After four weeks, as long as you're tolerating the medicine well, you'll move up to a stronger dose
Lifestyle and Dietary Habits Diet, alcohol consumption, and lifestyle factors are reviewed to ensure better management outcomes and adherence
If sugar cravings persist despite reaching therapeutic doses, genetic testing may reveal whether an alternative compound, co-therapy, or dietary adjustment would be more effective for your underlying appetite biology
Required Actions: Eli Lilly must take immediate action to address any violations, including ceasing and desisting promotional communications that are misleading